http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d99851198bb801d0b52cf3dd2f650adf
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Tabrizi |
| name | Sarah J. Tabrizi Sarah J Tabrizi |
| given-name | Sarah J. Sarah J |
| organization-name | UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, UK Dementia Research Institute, Department of Neurodegenerative Diseases, University College London, London, UK Huntington's Disease Centre, University College London Queen Square Institute of Neurology London United Kingdom; UK Dementia Research Institute University College London London United Kingdom Department of Neurodegenerative Disease; University College London, Institute of Neurology; London United Kingdom From the Department of Neurodegenerative Diseases (C.E.-F., D.H.M., S.J.T.), Department of Clinical and Movement Neurosciences (A.L, F.M., E.M., G.D.L., M.M., K.P.B.), and Department of Neuromuscular Disorders (H.H.), UCL Queen Square Institute of Neurology, United Kingdom; Department of Neurosciences, Biomedicine and Movement Sciences (F.M.), University of Verona, Italy; St George's University of London (D.H.M.), United Kingdom; Department of Systems Medicine (G.D.L.), University of Rome Tor... UCL Huntington's Disease Centre, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, UK Dementia Research Institute, University College London, UK. Electronic address: s.tabrizi@ucl.ac.uk. Huntington's Disease Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, England Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College, London, SW7 2AZ, United Kingdom, Medical and Molecular Genetics, GKT School of Medicine, King's College London, London SE1 9RT, United Kingdom, The Sanger Building, Department of Biochemistry, Cambridge University, Cambridge, CB2 1QW, United Kingdom, and Department of Neurodegenerative Disease, Institute of Neurology, University College London, WC1N 3BG, United Kingdom Department of Neurodegenerative Diseases University College London Institute of Neurology and National Hospital for Neurology and Neurosurgery London UK University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom From the Huntington's Disease Research Centre (E.B.J., L.M.B., S.G., F.B.R., S.J.T., R.I.S., E.J.W.), UCL Institute of Neurology, London, UK; Clinical Neurochemistry Laboratory (K.B., H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Institut du Cerveau et de la Moelle épinière (A.D.), Sorbonne Universités, UPMC University Paris 06, UMRS 1127, INSERM, U 1127, CNRS, UMR 7225; APHP (A.D.), Genetics Department, Pitié-Salpêtrière University Hospital, Paris, France; Centre for Molecular Medicine... Huntington's Disease Centre, Department of Neurodegenerative Disease, and UK Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, University College London, London, UK. Department of Neurodegenerative Disease, UCL Huntington's Disease Centre; University College London Institute of Neurology; London United Kingdom From the Departments of Neurodegenerative Disease (D.J.H.M., P.M., E.J.W., S.M., S.J.T.) and Molecular Neuroscience (H.H.), UCL Institute of Neurology, London; MRC Prion Unit (M.P., J.B., T.C., G.A.), London; and Neurogenetics Unit (J.H., J.M.P., E.M., A.H., M.G.S., H.H.), National Hospital for Neurology and Neurosurgery, University College London Hospitals, UK. Huntington’s Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK Huntington's Disease Research Centre, UCL Institute of Neurology London UK Proteome Sciences PLC, Cobham, Surrey, United Kingdom, Department of Neurodegenerative Disease, Institute of Neurology, London, United Kingdom, King's College London School of Medicine, Guy's Hospital, London, United Kingdom, Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund, Sweden, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada, and Neuroimmunology Laboratory, National Hospital for Neurology... Huntington's Disease Research Centre, UCL Institute of Neurology London United Kingdom Department of Neurodegenerative Disease, UCL Huntington's Disease Centre, University College London Institute of Neurology, London, UK. Huntington’s disease Research Centre, UCL Institute of Neurology, University College London, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK University College London, London, United Kingdom s.tabrizi@ucl.ac.uk. Department of Neurodegenerative Disease University College London, Institute of Neurology London United Kingdom UCL Institute of Neurology, University College London, Queen Square, London, UK. Institute of Neurology, Department of Neurodegenerative Disease, UCL, London, UK Huntington's Disease Research Centre University College London Institute of Neurology London UK HD Research Centre, University College London Queen Square Institute of Neurology , UCL, London , UK UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK. s.tabrizi@ucl.ac.uk. 2Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, England, UK From the Department of Neurodegenerative Disease (N.A.A., S.J.T.), UCL Huntington's Disease Centre, University College London Institute of Neurology, UK; Departments of Neurology (N.A.A.) and Public Health and Primary Care (J.M.M.v.d.B.), Leiden University Medical Centre, the Netherlands; Department of Population Health Sciences (N.A.A.), German Center for Neurodegenerative Diseases (DZNE), Bonn; and Department of Neurology (G.B.L.), Ulm University Hospital, Germany. From F. Hoffman-La Roche, Ltd (S.A.S., G.P., O.S.K., D.T., J.J.S.), Roche Innovation Center, Basel, Switzerland; University of Rochester (P.A., S.M., E.R.D., K.D.K.), NY; University of Iowa (J.D.L., D.R.L.), Iowa City; Massachusetts General Hospital and Harvard Medical School (M.C., S.H.), Boston; CHDI Management/Foundation (C.S.), Princeton, NJ; University of British Columbia, Vancouver, Canada (B.R.L.); and University College London (S.J.T.), UK. UCL Huntington’s Disease Centre, Queen Square Institute of Neurology, University College London , London , UK; UK Dementia Research Institute at University College London , London , UK UCL Huntington’s Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, WC1N 3BG, UK Huntington’s Disease Centre, Department of Neurodegenerative Disease, University College London, Queen Square, London, United Kingdom Huntington's Disease Research Centre, Institute of Neurology University College London London Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom; National Hospital for Neurology and Neurosurgery Queen Square, London WC1N 3BG United Kingdom UCL Huntington's Disease Centre, Queen Square Institute of Neurology London UK Huntington's Disease Research Center, Department of Neurodegenerative Disease University College London, Queen Square Institute of Neurology London United Kingdom Department of Neurodegenerative Disease Institute of Neurology, University College London London UK Huntington’s Disease Centre, Department of Neurodegenerative Disease and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, UCL, Queen Square, WC1N 3BG, UK UCL Institute of Neurology, University College London, UK University College London, Institute of Neurology Queen Square London UK UCL Institute of Neurology, University College London, Department of Neurodegenerative Disease, Queen Square, London, UK. sarah.tabrizi@prion.ucl.ac.uk UCL Huntington's disease Centre UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery Queen Square London UK Huntington’s Disease Centre, UCL Institute of Neurology, University College London, Queen Square, London, United Kingdom Department of Neurodegenerative Disease University College London Institute of Neurology, University College London London UK Huntington's Disease Research Centre, Institute of Neurology University College London London United Kingdom; Wellcome Trust Centre for Neuroimaging, Institute of Neurology University College London London United Kingdom UCL Institute of Neurology; University College London; Queen Square; London; WC1N 3BG; United Kingdom Huntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Dementia Research Institute at University College London, London, UK. Department of Neurodegenerative Disease, Institute of Neurology University College London London WC1N 3BG United Kingdom From University College London (UCL) Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL, and the U.K. Dementia Research Institute at UCL, London (S.J.T., E.J.W.), the Department of Clinical Neuroscience, Addenbrooke's Hospital, University of Cambridge, Cambridge (R.A.B., N.F.B.), Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, and the Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester (D.C.), the University of Edinburgh and the U.K. Dementia Research Institute, Edinburgh (J.P.), the Institute of Clinical Sciences, College of Medical and Dental Sciences, University Hospital Birmingham, Birmingham (H.R.), and the Cardiff University Brain Repair Group, Brain Repair and Intracranial Neurotherapeutics Unit, Neuroscience and Mental Health Research Institute and School of Biosciences, Cardiff (A.R.) - all in the United Kingdom; the Centre for Huntington's Disease, Department of Medical Genetics, and the Division of Neurology, Department of Medicine, University of British Columbia, and the Centre for Molecular Medicine and Therapeutics, B.C. Children's Hospital, Vancouver, Canada (B.R.L.); the Department of Neurology, Ulm University, Huntington's Disease Centre, Ulm (G.B.L.), the Department of Neurology, Huntington Center North Rhine-Westphalia, Ruhr University Bochum, St. Josef-Hospital, Bochum (C.S.), and the Department of Neuropsychiatry, Charité-Universitätsmedizin Berlin, Deutsches Zentrum für Neurodegenerative Erkrankungen, Berlin (J.P.) - all in Germany; Ionis Pharmaceuticals, Carlsbad, CA (H.B.K., E.E.S., D.A.N., T.B., E.P., A.V.S., C.F.B., R.M.L.); and F. Hoffmann-La Roche, Basel, Switzerland (C.C., I.G., S.A.S.). Huntington’s Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London , London WC1N 3BG , UK; Dementia Research Centre, University College London , London WC1N 3AR , UK Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, Russell Square House, London WC1B 5EH, UK; Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London WC1N 3AR, UK Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom. From the Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK. UCL Huntington’s Disease Centre, Queen Square Institute of Neurology, University College London, London WC1B 5EH, UK; UK Dementia Research Institute at University College London, London WC1E 6BT, UK Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; National Hospital for Neurology and Neurosurgery, Queen Square, London, UK Department of Neurodegenerative Disease and Dementia Research Institute, UCL, UK Department of Neurodegenerative Disease, Institute of Neurology, University College London London, UK. Huntington's Disease Research Centre University College London 2nd Floor Russell Square House, 10‐12 Russell Square London WC1B 5EH United Kingdom UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology University College London London United Kingdom; Department of Neurodegenerative Disease, Queen Square Institute of Neurology University College London London United Kingdom; UK Dementia Research Institute University College London London United Kingdom UCL Institute of Neurology, University College London, Queen Square, London, UK. s.tabrizi@ucl.ac.uk UCL Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Dementia Research Institute at UCL, Huntington’s Disease Centre, London WC1N 3BG, UK Institute of Neurology University College London London United Kingdom Department of Neurodegenerative Disease University College London Institute of Neurology London United Kingdom Huntington's Disease Centre, UCL Institute of Neurology Department of Neurodegenerative Disease, University College London London UK Huntington's Disease Centre Institute of Neurology University College London London UK Department of Neurodegenerative Disease UCL Institute of Neurology, National Hospital for Neurology & Neurosurgery Queen Square London WC1N 3BG UK From the University Department of Clinical Neurosciences (Drs. Orth and Tabrizi, and Prof. Schapira), Royal Free and University College Medical School, and Institute of Neurology (Prof. Schapira), University College, London, UK. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom. Electronic address: s.tabrizi@ucl.ac.uk. Huntington's Disease Research Centre, Institute of Neurology University College London London UK Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom; National Hospital for Neurology and Neurosurgery Queen Square London WC1N 3BG United Kingdom. Department of Neurodegenerative Disease UCL Institute of Neurology London United Kingdom; National Hospital for Neurology and Neurosurgery London United Kingdom Department of Neurodegenerative Disease, University College London , London WC1B 5EH , UK Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, London, UK Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom; and Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, WC1N 3BG, UK; Dementia Research Institute at UCL, London WC1N 3BG, UK. Electronic address: s.tabrizi@ucl.ac.uk. From CHDI Management/CHDI Foundation (B.B., J.W., C.S.), Princeton, NJ; Centre for Molecular Medicine and Therapeutics (B.R.L.), Department of Medical Genetics, University of British Columbia, Vancouver, Canada; UCL Institute of Neurology (S.J.T.), University College London, Queen Square, London, UK; Department of Neurology (R.A.C.R.), Leiden University Medical Centre, Leiden, the Netherlands; Department of Genetics and Cytogenetics (A.D.), UPMC Université Paris 06, UMR S975 Hôpital de la... Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK Department of Neurodegenerative Disease, Institute of Neurology University College London London UK Huntington's Disease Research Centre UCL Institute of Neurology, University College London United Kingdom UCL Institute of Neurology, University College London, London, UK. sarah.tabrizi@prion.ucl.ac.uk Huntington's Disease Centre, Department of Neurodegenerative Disease, University College London (UCL) Queen Square Institute of Neurology, and the UK Dementia Research Institute at UCL, London, United Kingdom. Huntington's Disease Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK; UK Dementia Research Institute at UCL, London, UK. University College London (UCL), Huntington's Disease Centre; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL; UK Dementia Research Institute at UCL, London, UK Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, United Kingdom. Electronic address: s.tabrizi@prion.ucl.ac.uk. UCL Institute of Neurology, University College London, Queen Square, London, UK Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London UCL Institute of Neurology, University College London, London, UK Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK University College London Queen Square Institute of Neurology, London, United Kingdom s.tabrizi@ucl.ac.uk. S.J. Tabrizi, FRCP, PhD, FMedSci, BSc(Hons), Department of Neurodegenerative Diseases, UCL Institute of Neurology, University College London, Queen Square, London, United Kingdom. Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom; Department of Neurodegenerative Disease University College London, Institute of Neurology Queen Square London United Kingdom Huntington's Disease Research Centre, UCL Institute of Neurology, London, UK Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK; The National Hospital for Neurology and Neurosurgery (NHNN), London, UK UCL Institute of Neurology University College London Queen Square London UK Huntington's Disease Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology University College London London UK |
Incoming Links
Total number of triples: 368.